Last week Britain became the first country in the world to approve the potentially game-changing COVID-19 antiviral pill, jointly developed by U.S.-based Merck & Co Inc and Ridgeback Biotherapeutics.
The government said in October it had secured 480,000 courses of the Merck drug, as well as 250,000 courses of an antiviral pill developed by Pfizer Inc (PFE.N).
Asked about the molnupiravir approval, Hopkins told BBC television: "That is great news and it will start to be rolled out through a drug trial at the end of this month/the beginning of December."
Hopkins said all the trials so far had been done with the unvaccinated, so this would help understand how it will work in the wider vaccinated population.
"The new Pfizer drug is probably not going to be licensed until the new year some time," she added. "It is still likely to be a couple of months away."
资料来源：https://www.reuters.com/business/healthcare-pharmaceuticals/uk-roll-out-covid-19-antiviral-drug-trial-this-month-health-security-agency-2021-11-07/
上述资料仅供参考。世纪21奇丰国际没有就该等资料的准确性或完整性，或在任何特定情况下使用的合适性作出任何明示或隐含的保证，亦无须对与该等资料或本网站有关的任何原故而引致的任何损失或损害负上责任。如有需要，请向相关部门或机构。